Real Vaccine Efficacy Rates Are Much Lower Than Previously Estimated
Don't expect any press releases from Pfizer or CDC MMWR updates on this
Vaccine efficacy is one of the most important questions of the pandemic.
World altering policy has been enacted due to the original estimates which ranged from 95-100%, according to The Experts™.
Those figures are still being endlessly referenced by politicians and prominent media figures when they inevitably test positive and thank the protection the vaccine provided for them.
Pfizer’s press release of the trial data specifically and triumphantly declared that their tests resulted in a 95% vaccine efficacy rate:
BNT162b2, met all of the study’s primary efficacy endpoints. Analysis of the data indicates a vaccine efficacy rate of 95% (p<0.0001) in participants without prior SARS-CoV-2 infection (first primary objective) and also in participants with and without prior SARS-CoV-2 infection (second primary objective), in each case measured from 7 days after the second dose. The first primary objective analysis is based on 170 cases of COVID-19, as specified in the study protocol, of which 162 cases of COVID-19 were observed in the placebo group versus 8 cases in the BNT162b2 group. Efficacy was consistent across age, gender, race and ethnicity demographics. The observed efficacy in adults over 65 years of age was over 94%.
Disgraceful discrimination and obsessive commentary that the “unvaccinated” should be banned from society and removed from healthcare systems has been a consistent feature of the post-vaccine era of the pandemic in large part due to these estimates.
For many prominent international media figures, it’s still a part of their COVID discourse:
But a recently released study, conducted as a systematic review of collected research, provides yet another contradiction to the 95%-100% rates, push for endless boosters and false sense of superiority from obnoxious commentators like Butterworth.